0000950103-21-009179.txt : 20210622
0000950103-21-009179.hdr.sgml : 20210622
20210622171155
ACCESSION NUMBER: 0000950103-21-009179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210617
FILED AS OF DATE: 20210622
DATE AS OF CHANGE: 20210622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Malik Shahzad
CENTRAL INDEX KEY: 0001380178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39430
FILM NUMBER: 211036185
MAIL ADDRESS:
STREET 1: 2273 RESEARCH BLVD, SUITE 400
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Acutus Medical, Inc.
CENTRAL INDEX KEY: 0001522860
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 451306615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2210 FARADAY AVE
STREET 2: SUITE 100
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 442-232-6080
MAIL ADDRESS:
STREET 1: 2210 FARADAY AVE
STREET 2: SUITE 100
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
dp152982_4-malik.xml
FORM 4
X0306
4
2021-06-17
0
0001522860
Acutus Medical, Inc.
AFIB
0001380178
Malik Shahzad
C/O ACUTUS MEDICAL, INC.
2210 FARADAY AVE., SUITE 100
CARLSBAD
CA
92008
1
0
0
0
Common Stock
2021-06-17
4
A
0
1800
0
A
4022
D
Common Stock
65436
I
See footnote
Common Stock
1551713
I
See footnote
Stock Options (Right to Buy)
16.66
2021-06-17
4
A
0
7022
0
A
2031-06-17
Common Stock
7022
7022
D
Each annual restricted stock unit ("Annual RSU") will be scheduled to vest as to all of the shares of Common Stock ("Shares") subject to such Annual RSU on the first anniversary of the date of grant of such Annual RSU, if on such date the Reporting person has remained in continuous service as a director
These shares are held by Advent Life Sciences LLP ("Advent"). The Reporting Person is a general partner of Advent, and disclaims beneficial ownership of the securities held by Advent except to the extent of his indirect pecuniary interest therein.
These shares are held by Advent Life Sciences Fund I LP. Advent is the general partner of Advent Life Sciences Fund II LP and the Reporting Person is a general partner of Advent. The Reporting Person disclaims beneficial ownership of the securities held by Advent Life Sciences Fund II LP except to the extent of his indirect pecuniary interest therein.
Each annual stock option (the "Annual Option") will be scheduled to vest and become exercisable as to all of the Shares subject to such Annual Option on the first anniversary of the date of grant of such Annual Option, if on such date the Reporting Person has remained in continuous service as a director.
/s/ Tom Sohn as attorney-in-fact for Shahzad Malik
2021-06-21